It is estimated that more than 6 million children and teens have migraine in the U.S. and many continue to have headaches as they age. However, two preventive drugs that may help them in adulthood may not help them as children, according to a study….
Last month the U.S. Food and Drug Administration (FDA) approved Treximet (sumatriptan and naproxen sodium) for use in pediatric patients 12 years of age and older for the acute treatment of migraine with or without aura. Treximet is the first approved combination and first approved…
The Food and Drug Administration recently approved topiramate for migraine prevention in adolescents, but a recent report has raised concerns that it may increase the risk of eating disorders in some teens. Writing in the journal Pediatrics, Jocelyn Lebow, PhD, a child and adolescent psychologist…
Q. I noticed that shortly after starting Topamax, I saw flashing lights in my vision, as if someone were taking a picture with a flash. I was told it had nothing to do with Topamax or my eyes, but I would like to know if…
The U.S. Food and Drug Administration (FDA) recently approved Topamax (topiramate) for prevention of migraine headaches in adolescents ages 12 to 17. Topiramate is the first drug to earn FDA approval for migraine prevention in this age group. Although it was prescribed for young migraineurs…
Children and teens are frequently prescribed the same migraine medications as adults, but two new studies show that medications to prevent and treat migraine in the pediatric population frequently fall short. The results of the studies, which appeared in JAMA Pediatrics last month, also showed that…
The US Food and Drug Administration (FDA) has issued a new warning about possible birth defects linked to topiramate (Topamax®), an antiseizure drug that is used to prevent migraine as well as treat epilepsy. The warning came after two pregnancy registries found an increased risk…
Topiramate (Topamax®) is the most important advance in migraine prevention, according to two Norwegian headache specialists writing in The Lancet. The antiseizure drug has long been used to treat epilepsy, but received FDA approval for migraine prevention in 2004. Topiramate is a cost-effective treatment that…
The US Food and Drug Administration (FDA) has approved generic versions of topiramate (Topamax®), an antiseizure medication also used to prevent migraine. The approval covers tablets in several strengths from 17 different manufacturers. Topiramate for migraine prevention also received a thumbs-up in a report published…
Subscribe to our Newsletter
Gain access to the most current migraine and headache information, prevention,
treatment, research, and news.
